Procter & Gamble Health Limited

NSEI:PGHL Stock Report

Market Cap: ₹78.8b

Procter & Gamble Health Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Milind Thatte

Chief executive officer

₹25.2m

Total compensation

CEO salary percentage100.0%
CEO tenure6.1yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.9yrs

Recent management updates

We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Nov 17
We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)

Feb 14
Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)

Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00

Sep 29
Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00

Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 10
Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 27
Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)

Mar 30
A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)

We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Nov 17
We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right

Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50

Oct 23
Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50

Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50

Oct 09
Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50

Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit

Feb 16
Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit

Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?

Oct 04
Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?

Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock

May 10
Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock

Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?

Mar 23
Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?

Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 02
Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?

Jan 31
Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?

Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like

Jan 10
Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like

Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?

Dec 19
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?

Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?

Dec 01
Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?

CEO Compensation Analysis

How has Milind Thatte's remuneration changed compared to Procter & Gamble Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₹2b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023₹25m₹25m

₹2b

Mar 31 2023n/an/a

₹2b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹2b

Jun 30 2022₹39m₹39m

₹2b

Mar 31 2022n/an/a

₹2b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹2b

Jun 30 2021₹32m₹32m

₹2b

Mar 31 2021n/an/a

₹2b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020₹17m₹26m

₹2b

Mar 31 2020n/an/a

₹2b

Dec 31 2019n/an/a

₹2b

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹1b

Mar 31 2019n/an/a

₹1b

Dec 31 2018₹20m₹13m

₹1b

Compensation vs Market: Milind's total compensation ($USD302.08K) is about average for companies of similar size in the Indian market ($USD381.03K).

Compensation vs Earnings: Milind's compensation has been consistent with company performance over the past year.


CEO

Milind Thatte (54 yo)

6.1yrs

Tenure

₹25,184,000

Compensation

Mr. Milind Vasant Thatte, M.Pharm.Sci., M.B.A., has been Managing Director and Executive Director of Procter & Gamble Health Limited (formerly known as Merck Limited) since April 1, 2018. Mr. Thatte had a...


Board Members

NamePositionTenureCompensationOwnership
Milind Thatte
MD & Executive Director6.1yrs₹25.18mno data
Lokesh Chandak
CFO, Finance Head & Executive Director1.1yrs₹27.76mno data
Suresh Talwar
Non-Executive Independent Chairman of the Board40.3yrs₹2.38m0.036%
₹ 28.1m
Subramanian Madhavan
Non-Executive Independent Director2.5yrs₹2.13mno data
Rani Jadhav
Non-Executive Independent Director9.3yrs₹2.20mno data
Aalok Agrawal
Non-Executive Director4.9yrsno datano data
Seema Sambasivan
Non-Executive Director1.1yrsno datano data

4.9yrs

Average Tenure

67yo

Average Age

Experienced Board: PGHL's board of directors are considered experienced (4.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.